Rosen Law Firm reminds purchasers of Regencell Bioscience Holdings Limited securities between October 28, 2024 and October 31, 2025 of the June 23, 2026 lead plaintiff deadline in a securities class action. If you purchased Regencell securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The lawsuit alleges that throughout the Class Period, defendants made false or misleading statements and failed to disclose that Regencell was vulnerable to market manipulation, exposing investors to significant financial risk and heightened regulatory scrutiny. Investors with losses in excess of $100,000 are encouraged to secure counsel before the deadline.
Regencell Bioscience Holdings LtdSecurities class action lawsuit alleging false statements and market manipulation exposure.